Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
GPR30 Differentially Regulates Short Latency Responses of Luteinising Hormone and Prolactin Secretion to Oestradiol
Journal of Neuroendocrinology, 08/24/09
Etgen AM et al. – The findings suggest that activation of GPR30 promotes short latency prolactin secretion but does not mediate E2 negative–feedback inhibition of LH secretion or E2 facilitation of female reproductive behaviour.
Related Articles
GPR30 and estrogen receptor expression: New insights into hormone dependence of inflammatory breast cancer
Breast Cancer Research and Treatment, 11/16/09
Relevance Score: 95%
Today in Reproductive Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Metformin Reduces Arterial Stiffness and Improves Endothelial Function in Young Women with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled, Crossover Trial
Journal of Clinical Endocrinology and Metabolism, 12/16/09
Associations of Birthweight and Gestational Age with Reproductive and Metabolic Phenotypes in Women with Polycystic Ovarian Syndrome and Their First-Degree Relatives
Journal of Clinical Endocrinology and Metabolism, 12/16/09
A new FSHbeta mutation in a 29 year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH
European Journal of Endocrinology, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


